Beneficial response to anakinra and thalidomide in Schnitzler's syndrome

Annals of the Rheumatic Diseases

Volumn 65, Issue 4, 2006, Pages 542-544

  De Koning, H D ^a   Bodar, E J ^a   Simon, A ^a   Van Der Hilst, J C H ^a   Netea, M G ^a   Van Der Meer, J W M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN A; DAPSONE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; THALIDOMIDE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC TEST; DNA DETERMINATION; DOSE RESPONSE; FEMALE; FEVER; FOLLOW UP; GAMMOPATHY; HUMAN; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; POLYNEUROPATHY; PRIORITY JOURNAL; REMISSION; SCHNITZLER SYNDROME; SKIN DEFECT; TREATMENT OUTCOME;

ANTIRHEUMATIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-1; SCHNITZLER SYNDROME; SIALOGLYCOPROTEINS; THALIDOMIDE; TREATMENT OUTCOME;

EID: 33645119818     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.045245     Document Type: Article

References (15)

1. Lipsker D, Veran Y, Grunenberger F, Cribier B, Heid E, Grosshans E. The Schnitzler syndrome. Four new cases and review of the literature. Medicine (Baltimore) 2001;80:37-44.
2. Schnitzler L, Hurez D, Verret JL. Chronic urticaria - hyperostosis - macroglobulinemia. Ann Dermatol Venereol 1989;116:547-50.
3. Almerigogna F, Giudizi MG, Cappelli F, Romagnani S. Schnitzler's syndrome: what's new? J Eur Acad Dermatol Venereol 2002;16:214-19.
4. Hawkins PN, Lachmann HJ, Aganna E, McDermott MF. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 2004;50:607-12.
5. Akimoto R, Yoshida M, Matsuda R, Miyasaka K, Itoh M. Schnitzler's syndrome with IgG kappa gammopathy. J Dermatol 2002;29:735-8.
6. Pascual-Lopez M, Hernandez-Nunez A, Sanchez-Perez J, Fernandez-Herrera J, Garcia-Diez A. Schnitzler's syndrome with monoclonal IgG kappa gammopathy: good response to cyclosporin. J Eur Acad Dermatol Venereol 2002;16:207-70.
7. Worm M, Kolde G. Schnitzler's syndrome: successful treatment of two patients using thalidomide. Br J Dermatol 2003;148:601-2.
8. Simon A, Fiselier TJW, Bodar FJ, Cuppen MPJM, van der Hilst JCH, Drenth JPH, et al. Beneficial response to interleukin-1-receptor antagonist in a patient with severe, treatment-resistant TNF-receptor associated periodic syndrome (TRAPS). Am J Med 2004;117:208-10.
9. Bodar EJ, Van der Hilst JCH, Drenth JPH, Van der Meer JWM, Simon A. Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Neth J Med 2005;63:260-4.
10. Schartz NEC, Buder S, Sperl H, Audring H, Paus R, Tebbe B, et al. Report of a case of Schnitzler's syndrome treated successfully with interferon alpha 2b. Dermatology 2002;205:54-6.
11. Kuenzti S, Buchet S, Saurat JH. Successful treatment of Schnitzler's syndrome with interferon alfa-2b. Dermatology 2002;205:74.
12. Saurat JH, Schifferli J, Steiger G, Dayer JM, Didierjean L. Anti-interleukin-1-alpha autoantibodies in humans - characterization, isotype distribution, and receptor-binding inhibition - higher frequency in Schnitzler syndrome (urticaria and macroglobulinemia). J Allergy Clin Immunol 1991;88:244-56.
13. Lipsker D, Spehner D, Drillien R, Schmitt P, Cribier B, Heid E, et al. Schnitzler syndrome: heterogeneous immunopathological findings involving IgM-skin interactions. Br J Dermatol 2000;142:954-9.
14. de Kleijn EMHA, Telgt D, Loan R. Schnitzler's syndrome presenting as fever of unknown origin (FUO) - the role of cytokines in its systemic features. Neth J Med 1997;51:140-2.
15. Morita A, Sakakibara S, Yokota M, Tsuji T. A case of urticarial vasculitis associated with macroglobulinemia (Schnitzler's syndrome). J Dermatol 1995;22:32-5.